Healthcare provider profile · identity verified

Michael Raphelson, MD

Family Medicine · KALAMAZOO, MI · NPI 1225008790

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	313	41
Levothyroxine Sodium	Levothyroxine Sodium	293	25
Amlodipine Besylate	Amlodipine Besylate	231	18
Metoprolol Succinate	Metoprolol Succinate	220	28
Gabapentin	Gabapentin	219	26
Lisinopril	Lisinopril	187	24
Furosemide	Furosemide	166	27
Sertraline Hcl	Sertraline Hcl	162	17
Omeprazole	Omeprazole	159	22
Rosuvastatin Calcium	Rosuvastatin Calcium	144	18
Losartan Potassium	Losartan Potassium	140	15
Clopidogrel	Clopidogrel Bisulfate	136	16
Famotidine	Famotidine	136	17
Pantoprazole Sodium	Pantoprazole Sodium	134	21
Isosorbide Mononitrate Er	Isosorbide Mononitrate	122	suppressed
Lamotrigine	Lamotrigine	118	suppressed
Hydralazine Hcl	Hydralazine Hcl	106	suppressed
Trazodone Hcl	Trazodone Hcl	104	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	93	27
Donepezil Hcl	Donepezil Hcl	90	suppressed
Tramadol Hcl	Tramadol Hcl	86	suppressed
Duloxetine Hcl	Duloxetine Hcl	81	suppressed
Eliquis	Apixaban	81	15
Pregabalin	Pregabalin	81	suppressed
Meloxicam	Meloxicam	78	suppressed
Potassium Chloride	Potassium Chloride	78	13
Trulicity	Dulaglutide	78	suppressed
Buspirone Hcl	Buspirone Hcl	74	12
Dapagliflozin	Dapagliflozin Propanediol	71	suppressed
Mirtazapine	Mirtazapine	71	suppressed
Memantine Hcl	Memantine Hcl	68	suppressed
Lacosamide	Lacosamide	67	suppressed
Metformin Hcl	Metformin Hcl	67	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	66	31
Metformin Hcl Er	Metformin Hcl	65	suppressed
Levetiracetam	Levetiracetam	62	suppressed
Propranolol Hcl	Propranolol Hcl	58	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	56	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	52	suppressed
Movantik	Naloxegol Oxalate	51	suppressed
Buprenorphine	Buprenorphine	50	11
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	50	14
Montelukast Sodium	Montelukast Sodium	49	suppressed
Prednisone	Prednisone	47	25
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	46	suppressed
Xarelto	Rivaroxaban	46	suppressed
Bupropion Xl	Bupropion Hcl	45	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	45	suppressed
Topiramate	Topiramate	45	suppressed
Carvedilol	Carvedilol	42	suppressed
Chlorthalidone	Chlorthalidone	42	suppressed
Primidone	Primidone	40	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	39	suppressed
Baclofen	Baclofen	35	suppressed
Divalproex Sodium Er	Divalproex Sodium	34	suppressed
Fentanyl	Fentanyl	33	suppressed
Olanzapine	Olanzapine	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Mirabegron Er	Mirabegron	32	suppressed
Simvastatin	Simvastatin	32	suppressed
Bumetanide	Bumetanide	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Metolazone	Metolazone	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Amiodarone Hcl	Amiodarone Hcl	26	suppressed
Ranolazine Er	Ranolazine	26	suppressed
Memantine Hcl Er	Memantine Hcl	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Finasteride	Finasteride	24	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	24	suppressed
Divalproex Sodium	Divalproex Sodium	23	suppressed
Torsemide	Torsemide	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Cephalexin	Cephalexin	21	16
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	suppressed
Trospium Chloride Er	Trospium Chloride	20	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	18	suppressed
Fluoxetine Dr	Fluoxetine Hcl	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Jardiance	Empagliflozin	18	suppressed
Levofloxacin	Levofloxacin	18	13
Oxycodone Hcl	Oxycodone Hcl	18	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Alprazolam Er	Alprazolam	17	suppressed
Clonazepam	Clonazepam	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Mesalamine	Mesalamine	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Ozempic	Semaglutide	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Acamprosate Calcium	Acamprosate Calcium	14	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Potassium Citrate Er	Potassium Citrate	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Clonidine	Clonidine	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Naproxen	Naproxen	13	suppressed
Otezla	Apremilast	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Exemestane	Exemestane	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error